Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Fatigue and weakness hinder patient social reintegration after liver transplantation

So Hyun Kang, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Sungho Kim, Kil Hwan Kim, In Gun Hyun, Ahmed Shehta

Clin Mol Hepatol. 2018;24(4):402-408. Published online October 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0028

View: 10407 Download: 116 Web of Science: 11 Crossref: 10

3

Validation of the Korean Version of Liver Disease Quality of Life (LDQOL 1.0) Instrument

Sehyun Kim, Ph.D. Ki Hyun Choi, M.D. Seong Gyu Hwang, M.D. Ji Hyun Lee, M.D. Sun Young Kwak, M.D. Pil Won Park, M.D. Yukyung Kim, M.D. Hye Ja Park, Ph.D. Soon Joo Kim, M.A. Kyu Sung Rim M.D.

Clin Mol Hepatol. 2007;13(1):44-50. Published online January 1, 1970

View: 3042 Download: 67

1

Assessment of Health-related Quality of Life in Patients with Chronic Liver Disease

Sang Hwa Urm

Clin Mol Hepatol. 2007;13(1):5-8. Published online January 1, 1970

View: 2822 Download: 18

3

Assessment of Quality of Life and Associated Factors in Patients with Chronic Viral Liver Disease

Chang Keun Park, M.D., Soo Young Park, M.D., Eun Soo Kim, M.D., Jin Hyung Park, M.D., Dong Woo Hyun, M.D., Young Mi Yun, M.D., Chang Min Jo, M.D., Won Young Tak, M.D., Young Oh Kweon, M.D., Sung Kook Kim, M.D., Yong Hwan Choi, M.D. and Shin Goo Park, M.D.

Clin Mol Hepatol. 2003;9(3):212-221. Published online January 1, 1970

View: 3131 Download: 32

7

Comorbidities and Quality of Life in Patients with Interferon - Refractory Chronic Hepatitis C. Fontana RJ , Moyer CA , Sonnad S , et al. Am J Gastroenterol 2001 ; 96 ; 170 - 178

Byung Ik Kim

Clin Mol Hepatol. 2001;7(2):220-221. Published online January 1, 2000

View: 2448 Download: 13

1 |

Viewed By 5241	MAFLD: How is it different from NAFLD?
Viewed By 4999	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4674	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4651	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search